Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT07280234

Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma.

Comparison of Intradermal Microinjections of Tanexamic Acid and Oral Tranexamic Acid in the Management of Melasma. A Randomized Controlled Trial.

Sponsor: Hayat Abad Medical Complex, Peshawar

Conditions Melasma

Interventions Intradermal microinjections of tranexamic acid Oral tranexamic acid

Updated 2 times since 2026 Last updated: Dec 11, 2025 Started: Nov 14, 2024 Primary completion: May 15, 2025 Completion: May 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07280234, this EARLY_PHASE1 trial focuses on Melasma and remains completed. Sponsored by Hayat Abad Medical Complex, Peshawar, it has been updated 2 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Feb 2026 — Present [monthly]

Completed EARLY_PHASE1
Jan 2026 — Feb 2026 [monthly]

Completed EARLY_PHASE1

First recorded

Nov 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hayat Abad Medical Complex, Peshawar

Data source: Hayat Abad Medical Complex, Peshawar

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Peshawar, Pakistan